Decorin prevents the development of juvenile communicating hydrocephalus

Brain

Volumn 136, Issue 9, 2013, Pages 2842-2858

  Botfield, Hannah ^a   Gonzalez, Ana Maria ^a   Abdullah, Osama ^b   Skjolding, Anders Dæhli ^c   Berry, Martin ^a   Mcallister, James Pat ^b,d   Logan, Ann ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Department of Electrical and Computer Engineering   (United States)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

decorin; fibrosis; hydrocephalus; Smad; TGF

Indexed keywords

DECORIN; FIBRONECTIN; KAOLIN; LAMININ; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL CISTERN; BRAIN VENTRICLE DILATATION; COMMUNICATING HYDROCEPHALUS; CONTROLLED STUDY; ENCEPHALITIS; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SUBARACHNOID SPACE;

EID: 84883396629     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt203     Document Type: Article

References (76)

1. Abramoff MD, Magalhaes PJ, Ram SJ. Image Processing with ImageJ. Biophotonics Int 2004; 11: 36-42.
2. Aquilina K, Hobbs C, Tucker A, Whitelaw A, Thoresen M. Do drugs that block transforming growth factor beta reduce posthaemorrhagic ventricular dilatation in a neonatal rat model? Acta Paediatr 2008; 97: 1181-6.
3. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 1983; 258: 7155-60.
4. Bidanset DJ, LeBaron R, Rosenberg L, Murphy-Ullrich JE, Hook M. Regulation of cell substrate adhesion: effects of small galactosaminoglycan- containing proteoglycans. J Cell Biol 1992; 118: 1523-31.
5. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney diasease. Nature 1992; 360: 361-4.
6. Cherian S, Thoresen M, Silver IA, Whitelaw A, Love S. Transforming growth factor-betas in a rat model of neonatal posthaemorrhagic hydrocephalus. Neuropathol Appl Neurobiol 2004; 30: 585-600.
7. Comalada M, Cardo M, Xaus J, Valledor AF, Lloberas J, Ventura F, et al. Decorin reverses the repressive effect of autocrine-produced TGF-beta on mouse macrophage activation. J Immunol 2003; 170: 4450-6.
8. Csorda s G, Santra M, Reed CC, Eichstetter I, McQuillan DJ, Gross D, et al. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem 2000; 275: 32879-87.
9. Davies JE, Tang X, Denning JW, Archibald SJ, Davies SJ. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries. Eur J Neurosci 2004; 19: 1226-42.
10. Del Bigio MR. Neuropathology and structural changes in hydrocephalus. Dev Disabil Res Rev 2010a; 16: 16-22.
11. Del Bigio MR. Ependymal cells: biology and pathology. Acta Neuropathol 2010b; 119: 55-73.
12. Deren KE, Packer M, Forsyth J, Milash B, Abdullah OM, Hsu EW, et al. Reactive astrocytosis, microgliosis and inflammation in rats with neonatal hydrocephalus. Exp Neurol 2010; 226: 110-9.
13. Douglas MR, Daniel M, Lagord C, Akinwunmi J, Jackowski A, Cooper C, et al. High CSF transforming growth factor beta levels after subarachnoid haemorrhage: association with chronic communicating hydrocephalus. J Neurol Neurosurg Psychiatry 2009; 80: 545-50.
14. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003; 53: 123-35.
15. Eskandari R, Harris CA, McAllister JP 2nd. Reactive astrocytosis in feline neonatal hydrocephalus: acute, chronic, and shunt-induced changes. Childs Nerv Syst 2011; 27: 2067-76.
16. Flood C, Akinwunmi J, Lagord C, Daniel M, Berry M, Jackowski A, et al. Transforming growth factor-beta1 in the cerebrospinal fluid of patients with subarachnoid hemorrhage: titers derived from exogenous and endogenous sources. J Cereb Blood Flow Metab 2001; 21: 157-62.
17. Fukumizu M, Takashima S, Becker LE. Glial reaction in periventricular areas of the brainstem in fetal and neonatal posthemorrhagic hydrocephalus and congenital hydrocephalus. Brain Dev 1996; 18: 40-5.
18. Galbreath E, Kim S-J, Park K, Brenner M, Messing A. Overexpression of TGF-[beta]1 in the central nervous system of transgenic mice results in hydrocephalus. J Neuropathol Exp Neurol 1995; 54: 339-49.
19. Hatta J, Hatta T, Moritake K, Otani H. Heavy water inhibiting the expression of transforming growth factor-beta1 and the development of kaolin-induced hydrocephalus in mice. J Neurosurg 2006; 104: 251-8.
20. Hocking AM, Shinomura T, McQuillan DJ. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 1998; 17: 1-19.
21. Hoque N, Thoresen M, Aquilina K, Hogan S, Whitelaw A. Decorin and colchicines as potential treatments for post-haemorrhagic ventricular dilatation in neonatal rat model. Neonatology 2011; 100: 271-6.
22. Horinek D, Cihar M, Tichy M. Current methods in the treatment of posthemorrhagic hydrocephalus in infants. Bratisl Lek Listy 2003; 104: 347-51.
23. Iozzo RV, Schaefer L. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 2010; 277: 3864-75.
24. Jackowski A, Crockard A, Burnstock G, Russell RR, Kristek F. The time course of intracranial pathophysiological changes following experimental subarachnoid haemorrhage in the rat. J Cereb Blood Flow Metab 1990; 10: 835-49.
25. Khan OH, Enno TL, Del Bigio MR. Brain damage in neonatal rats following kaolin induction of hydrocephalus. Exp Neurol 2006; 200: 311-20.
26. Kanaji M, Tada T, Kobayashi S. A murine model of communicating hydrocephalus: role of TGF-beta1. J Clin Neurosci 1997; 4: 51-6.
27. Kitazawa K, Tada T. Elevation of transforming growth factor-beta 1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Stroke 1994; 25: 1400-4.
28. Kolb M, Margetts PJ, Galt T, Sime PJ, Xing Z, Schmidt M, et al. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med 2001; 163: 770-7.
29. Krumdieck R, Ho o k M, Rosenberg LC, Volanakis JE. The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J Immunol 1992; 149: 3695-701.
30. Krupinski J, Kumar P, Kumar S, Kaluza J. Increased expression of TGFbeta 1 in brain tissue after ischemic stroke in humans. Stroke 1996; 27: 852-7.
31. Lan HY. Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation. Int J Biol Sci 2011; 7: 1056-67.
32. Li J, McAllister JP 2nd, Shen Y, Wagshul ME, Miller JM, Egnor MR, et al. Communicating hydrocephalus in adult rats with kaolin obstruction of the basal cisterns or the cortical subarachnoid space. Exp Neurol 2008; 211: 351-61.
33. Logan A, Frautschy SA, Gonzalez AM, Sporn MB, Baird A. Enhanced expression of transforming growth factor beta 1 in the rat brain after localized cerebral injury. Brain Res 1992; 587: 216-25.
34. Logan A, Baird A, Berry M. Decorin attenuates gliotic scar formation in the rat cerebral hemisphere. Exp Neurol 1999a; 159: 504-10.
35. Logan A, Green J, Hunter A, Jackson R, Berry M. Inhibition of glial scarring in the injured rat brain by recombinant human monoclonal antibody to transforming growth factor-beta2. Eur J Neurosci 1999b; 11: 2367-74.
36. McAllister JP 2nd. Pathophysiology of congenital and neonatal hydrocephalus. Semin Fetal Neonatal Med 2012; 17: 285-94.
37. Miller JM, McAllister JP 2nd. Reduction of astrogliosis and microgliosis by cerebrospinal fluid shunting in experimental hydrocephalus. Cerebrospinal Fluid Res 2007; 4: 5.
38. Minor KH, Bournat JC, Toscano N, Giger RJ, Davies SJ. Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissue. Brain 2011; 134: 1140-55.
39. Mogi M, Harada M, Kondo T, Narabayashi H, Riederer P, Nagatsu T. Transforming growth factor beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease. Neurosci Lett 1995; 193: 129-32.
40. Moreth K, Iozzo RV, Schaefer L. Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle 2012; 11: 2084-91.
41. Moscatello DK, Santra M, Mann DM, McQuillan DJ, Wong AJ, Iozzo RV. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest 1998; 101: 406-12.
42. Motohashi O, Suzuki M, Shida N, Umezawa K, Ohtoh T, Sakurai Y, et al. Subarachnoid haemorrhage induced proliferation of leptomeningeal cells and deposition of extracellular matrices in the arachnoid granulations and subarachnoid space. Immunhistochemical study. Acta Neurochir (Wien) 1995; 136: 88-91.
43. Nagra G, Wagshul ME, Rashid S, Li J, McAllister JP 2nd, Johnston M. Elevated CSF outflow resistance associated with impaired lymphatic CSF absorption in a rat model of kaolin-induced communicating hydrocephalus. Cerebrospinal Fluid Res 2010; 7: 4.
44. Nakerakanti S, Trojanowska M. The role of TGF-beta receptors in fibrosis. Open Rheumatol J 2012; 6: 156-62.
45. National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs). Experimental design/statistics, 2012. http://www.nc3rs.org. uk/category.asp?catID=7 (5 December 2012, date last accessed)..
46. Neill T, Schaefer L, Iozzo RV. Decorin: a guardian from the matrix. Am J Pathol 2012a; 181: 380-7.
47. Neill T, Painter H, Buraschi S, Owens RT, Lisanti MP, Schaefer L, et al. Decorin antagonizes the angiogenic nework: concurrent inhibition of Met, hypoxia inducible factor 1a, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem 2012b; 287: 5492-506.
48. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005; 50: 427-34.
49. Rashid S, McAllister JP 2nd, Yu Y, Wagshul ME. Neocortical capillary flow pulsatility is not elevated in experimental communicating hydrocephalus. J Cereb Blood Flow Metab 2012; 32: 318-29.
50. Reese SP, Underwood CJ, Weiss JA. Effects of decorin proteoglycan on fibrillogenesis, ultrastructure, and mechanics of type I collagen gels. Matrix Biol 2013. (epub ahead of print).
51. Resch B, Gedermann A, Maurer U, Ritschl E, Muller W. Neurodevelopmental outcome of hydrocephalus following intra-/periventricular hemorrhage in preterm infants: short-and long-term results. Childs Nerv Syst 1996; 12: 27-33.
52. Sajanti J, Majamaa K. Detection of meningeal fibrosis after subarachnoid haemorrhage by assaying procollagen propeptides in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1999; 67: 185-8.
53. Sajanti J, Bjorkstrand AS, Finnila S, Heikkinen E, Peltonen J, Majamaa K. Increase of collagen synthesis and deposition in the arachnoid and the dura following subarachnoid hemorrhage in the rat. Biochim Biophys Acta 1999; 1454: 209-16.
54. Sajanti J, Heikkinen E, Majamaa K. Transient increase in procollagen propeptides in the CSF after subarachnoid hemorrhage. Neurology 2000; 55: 359-63.
55. Sajanti J, Heikkinen E, Majamaa K. Rapid induction of meningeal collagen synthesis in the cerebral cisternal and ventricular compartments after subarachnoid hemorrhage. Acta Neurochir 2001; 143: 821-6.
56. Shooman D, Portess H, Sparrow O. A review of the current treatment methods for posthaemorrhagic hydrocephalus of infants. Cerebrospinal Fluid Res 2009; 6: 1.
57. Shprecher D, Schwalb J, Kurlan R. Normal pressure hydrocephalus: diagnosis and treatment. Curr Neurol Neurosci Rep 2008; 8: 371-6.
58. Silva MCD. Pathophysiology of hydrocephalus. In: Cinalli G, Maixner WJ, Sainte-Rose C, editors. Pediatric hydrocephalus. Milano: Springer-Verlag; 2004. p. 65-76.
59. Slobodian I, Krassioukov-Enns D, Del Bigio MR. Protein and synthetic polymer injection for induction of obstructive hydrocephalus in rats. Cerebrospinal Fluid Res 2007; 4: 9.
60. Suzuki S, Ishii M, Ottomo M, Iwabuchi T. Changes in the subarachnoid space after experimental subarachnoid haemorrhage in the dog: scanning electron microscopic observation. Acta Neurochir (Wien) 1977; 39: 1-14.
61. Szabo A, Kalman M. Disappearance of the post-lesional laminin immunopositivity of brain vessels is parallel with the formation of gliovascular junctions and common basal lamina. A double-labelling immunohistochemical study. Neuropathol Appl Neurobiol 2004; 30: 169-77.
62. Takeuchi Y, Kodama Y, Matsumoto T. Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. J Biol Chem 1994; 269: 32634-8.
63. Tada T, Kanaji M, Kobayashi S. Induction of communicating hydrocephalus in mice by intrathecal injection of human recombinant transforming growth factor-beta 1. J Neuroimmunol 1994; 50: 153-8.
64. Unsicker K, Flanders KC, Cissel DS, Lafyatis R, Sporn MB. Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience 1991; 44: 613-25.
65. Verrecchia F, Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 2002; 118: 211-5.
66. Wagshul ME, McAllister JP, Rashid S, Li J, Egnor MR, Walker ML, et al. Ventricular dilation and elevated aqueductal pulsations in a new experimental model of communicating hydrocephalus. Exp Neurol 2009; 218: 33-40.
67. Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today 1989; 10: 258-61.
68. Wells RG. Fibrogenesis. V. TGF-beta signaling pathways. Am J Physiol Gastrointest Liver Physiol 2000; 279: 845-50.
69. Whitelaw A, Christie S, Pople I. Transforming growth factor-beta1: a possible signal molecule for posthemorrhagic hydrocephalus? Pediatr Res 1999; 46: 576-80.
70. Winnemo ller M, Scho n P, Vischer P, Kresse H. Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment. Eur J Cell Biol 1992; 59: 47-55.
71. Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, et al. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am J Pathol 1995; 147: 53-67.
72. Xaus J, Comalada M, Cardo M, Valledor AF, Celada A. Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1). Blood 2001; 98: 2124-33.
73. Xu H, Zhang SL, Tan GW, Zhu HW, Huang CQ, Zhang FF, et al. Reactive gliosis and neuroinflammation in rats with communicating hydrocephalus. Neuroscience 2012; 218: 317-25.
74. Yamada H, Yokota A, Furuta A, Horie A. Reconstitution of shunted mantle in experimental hydrocephalus. J Neurosurg 1992; 76: 856-62.
75. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990; 346: 281-4.
76. Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res 2009; 19: 128-39